Real-World Data (RWD) on the 3-Year Follow-Up Outcomes of Different CNS Prophylaxis Strategies Across CNS-IPI Risk Groups in Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

PURPOSE: CNS relapse in patients with diffuse large B-cell lymphoma (DLBCL) is associated with poor prognosis with a median survival of about 2.5 months. Data demonstrating best prophylactic strategy remain controversial and need further definition. PATIENTS AND METHODS: We present data of 110 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Faqah, Anadil, Asif, Summaiya, Goksu, Suleyman Yasin, Sheikh, Hassan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162514/
https://www.ncbi.nlm.nih.gov/pubmed/33835825
http://dx.doi.org/10.1200/GO.20.00422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162514/
https://www.ncbi.nlm.nih.gov/pubmed/33835825
http://dx.doi.org/10.1200/GO.20.00422

Ejemplares similares